Jere E. Meredith
Research and Development
Bristol Myers Squibb
5 Research Parkway
Wallingford
USA
Name/email consistency: high
- P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice. Meredith, J.E., Thompson, L.A., Toyn, J.H., Marcin, L., Barten, D.M., Marcinkeviciene, J., Kopcho, L., Kim, Y., Lin, A., Guss, V., Burton, C., Iben, L., Polson, C., Cantone, J., Ford, M., Drexler, D., Fiedler, T., Lentz, K.A., Grace, J.E., Kolb, J., Corsa, J., Pierdomenico, M., Jones, K., Olson, R.E., Macor, J.E., Albright, C.F. J. Pharmacol. Exp. Ther. (2008)
- Gamma-secretase activity is not involved in presenilin-mediated regulation of beta-catenin. Meredith, J.E., Wang, Q., Mitchell, T.J., Olson, R.E., Zaczek, R., Stern, A.M., Seiffert, D. Biochem. Biophys. Res. Commun. (2002)
